Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include rarely findings: Dystonia, Seizure, Microcephaly, and Brain shrinkage (cerebral atrophy). 40 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Mutism, Peripheral axonal neuropathy, Inability to walk |
GLE1 encodes GLE1 RNA export mediator (698 aa). Required for the export of mRNAs containing poly(A) tails from the nucleus into the cytoplasm. May be involved in the terminal step of the mRNA transport through the nuclear pore complex (NPC) Highest expression in Testis (66.4 TPM) and Cells EBV-transformed lymphocytes (52.3 TPM).
Lethal arthrogryposis-anterior horn cell disease syndrome is associated with mutations in the GLE1 gene on chromosome 9.
GLE1 is classified as a druggable target (Transporter category) with score 26.1.
Genetic testing for GLE1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for lethal arthrogryposis-anterior horn cell disease syndrome.
6 publications have been identified in PubMed for lethal arthrogryposis-anterior horn cell disease syndrome. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (33%), and Basic Science / Preclinical (17%).
Civit A (2026). [PMID: 41230573](https://pubmed.ncbi.nlm.nih.gov/41230573/). *Am J Med Genet A*. [Case Report / Case Series]
Haliloğlu G (2025). [PMID: 40356365](https://pubmed.ncbi.nlm.nih.gov/40356365/). *J Neuromuscul Dis*. [Review / Meta-Analysis]
Krygier M (2025). [PMID: 40519116](https://pubmed.ncbi.nlm.nih.gov/40519116/). *Am J Med Genet A*. [Case Report / Case Series]
Zárybnický T (2025). [PMID: 40674274](https://pubmed.ncbi.nlm.nih.gov/40674274/). *FEBS J*. [Basic Science / Preclinical]
Fare CM (2024). [PMID: 38383349](https://pubmed.ncbi.nlm.nih.gov/38383349/). *Nucleus*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 2:27 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
6 |
Generalized hypotonia, Skeletal muscle atrophy, Myopathic facies |
Head and neck | 3 | Facial diplegia, High palate, Microcephaly |
Bones and joints | 3 | Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis), Excessive outward curvature of the upper spine (kyphosis) |
Arms and legs | 3 | Hand clenching, Rocker bottom foot, Areflexia of lower limbs |
Lungs and breathing | 2 | Respiratory failure, Difficulty breathing due to muscle weakness (respiratory insufficiency due to muscle weakness) |
Pregnancy and birth | 1 | Fetal akinesia sequence |
Digestive system | 1 | Feeding difficulties |
Eyes | 1 | Ptosis |